APA (7th ed.) Citation

S, H., M, S., ES, D., M, N., SS, A., MR, P., . . . MP, B. (2025). Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD. Journal of the American Heart Association, 14(21), e039752. https://doi.org/10.1161/JAHA.124.039752

Chicago Style (17th ed.) Citation

S, Hogan, et al. "Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD." Journal of the American Heart Association 14, no. 21 (2025): e039752. https://doi.org/10.1161/JAHA.124.039752.

MLA (9th ed.) Citation

S, Hogan, et al. "Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD." Journal of the American Heart Association, vol. 14, no. 21, 2025, p. e039752, https://doi.org/10.1161/JAHA.124.039752.